Table 1a.

(Continued)

^aIf an age range was given in the paper, only the ages included in the trial are included in the analysis of the SEER data. Otherwise, when the mean or median age was given, a 50-year cohort around the median age was used.

^bFollow-up through 2006.

^cCould not be calculated because of an inadequate follow-up period.

Abbreviations: AP, accelerated phase; ARAC, cytarabine; BC, blast crisis; bid, twice daily; BeNeLux, Belgium, The Netherlands, and Luxembourg; BMT, bone marrow transplant; CML, chronic myelocytic leukemia; CP, chronic phase; CPA, cyclophosphamide; ECOG, Eastern Cooperative Oncology Group; HU, hydroxyurea; IFN, interferon; LRD, living related donor (stem cell transplant); MUD, matched unrelated donor (stem cell transplant); NA, not available; NS, not significant; OS, overall survival; PBSCT peripheral blood stem cell transplant; Peg-IFN-A pegylated interferon A; PS, performance status score; SCT, stem cell transplant; SE, standard error; SEER, Surveillance, Epidemiology, and End Results; vit A vitamin A; XRT, radiation therapy.